UM-HMC-1 Cells
General information
| Description | UM-HMC-1 is a human mucoepidermoid carcinoma cell line established from a primary salivary gland tumor of the anterior buccal gland of a 76-year-old African American male patient. The line is one of the University of Michigan Human Mucoepidermoid Carcinoma (UM-HMC) panel lines. UM-HMC-1 harbors a CRTC1-MAML2 gene fusion (also designated MECT1-MAML2), which is the defining oncogenic event in the majority of mucoepidermoid carcinomas and results from a t(11;19)(q21;p13) chromosomal translocation. This fusion activates CREB target genes and Notch pathway components, driving tumor proliferation and survival. UM-HMC-1 is applicable in studies of salivary gland mucoepidermoid carcinoma biology, CRTC1-MAML2 fusion oncogene signalling, CREB pathway activation, Notch pathway dysregulation, and therapeutic targeting of fusion-driven cancers. It is used in drug sensitivity assays, invasion and migration studies, and as part of the UM-HMC multi-line panel for comparative characterization of salivary gland tumor biology. |
|---|---|
| Organism | Human |
| Tissue | Salivary gland, anterior buccal gland |
| Disease | Salivary gland mucoepidermoid carcinoma |
| Metastatic site | Primary tumor site (anterior buccal gland, salivary gland) |
| Applications | Salivary gland carcinoma research; CRTC1-MAML2 fusion oncogene biology; CREB/Notch pathway studies; mucoepidermoid carcinoma drug sensitivity; fusion-driven cancer biology; UM-HMC panel studies |
| Synonyms | University of Michigan-Human Mucoepidermoid Carcinoma-1 |
Characteristics
| Age | 76 years |
|---|---|
| Gender | Male |
| Ethnicity | African American |
| Morphology | Epithelial-like |
| Cell type | Epithelial cells |
| Growth properties | Adherent |
Regulatory Data
| Citation | UM-HMC-1 (Cytion catalog number 305716) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_Y473 |
Biomolecular Data
| Mutational profile | Mutation: Gene fusion, CRTC1 + HGNC, MAML2, Name(s)=CRTC1-MAML2, MECT1-MAML2. |
|---|
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase, 20min 37°C |
| Doubling time | approx. 24 to 48 hours |
| Subculturing | Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium. |
| Split ratio | 1 to 5 |
| Seeding density | 1 to 3 x 104 cells/cm2 |
| Fluid renewal | Every 2 to 3 days |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Flask Coating | Use Collagen coated flasks |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305716-290526 | Certificate of Analysis | 17. Jul. 2026 | 305716 |
-
Related products
Related products
UM-HMC-3A CellsOrganism Human Tissue Oral cavity, hard palate Disease Hard palate mucoepidermoid carcinoma CAD$966.00*